Comparative efficacy and safety of generic rosuvastatin (K-zuva®) versus proprietary rosuvastatin (Crestor®) in patients with hypercholesterolemia: An open-label, 6-week randomized controlled trial
Pharmacy Practice · 12.03.2026 · 24 (1) · 1-7
DOI: 10.18549/pharmpract.2026.1.3277 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pharmacy Practice, online erschienen am 12.03.2026. Verfasst von Thanitha Sirirak und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sirirak, T., Siwamogsatham, S., Buranapin, S., Inthaphan, P., Manosroi, W., Pratipanawatr, T., Khamsai, S., Sangsupawanich, P., & Suwanugsorn, S. (2026). Comparative efficacy and safety of generic rosuvastatin (K-zuva®) versus proprietary rosuvastatin (Crestor®) in patients with hypercholesterolemia: An open-label, 6-week randomized controlled trial. Pharmacy Practice, 24(1), 1-7. https://doi.org/10.18549/pharmpract.2026.1.3277
Vancouver
Sirirak T, Siwamogsatham S, Buranapin S, Inthaphan P, Manosroi W, Pratipanawatr T, et al. Comparative efficacy and safety of generic rosuvastatin (K-zuva®) versus proprietary rosuvastatin (Crestor®) in patients with hypercholesterolemia: An open-label, 6-week randomized controlled trial. Pharmacy Practice. 2026;24(1):1-7. doi:10.18549/pharmpract.2026.1.3277
BibTeX
@article{Sirirak2026,
author = {Sirirak, Thanitha and Siwamogsatham, Sarawut and Buranapin, Supawan and Inthaphan, Piti and Manosroi, Worapaka and Pratipanawatr, Thongchai and Khamsai, Sittichai and Sangsupawanich, Pasuree and Suwanugsorn, Saranyou},
title = {Comparative efficacy and safety of generic rosuvastatin (K-zuva®) versus proprietary rosuvastatin (Crestor®) in patients with hypercholesterolemia: An open-label, 6-week randomized controlled trial},
journal = {Pharmacy Practice},
year = {2026},
volume = {24},
number = {1},
pages = {1--7},
doi = {10.18549/pharmpract.2026.1.3277}
}
EUVIMED